MétaCan
Menu
← Back to cohort
Record W4414277141 · doi:10.7759/cureus.92549

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Acute Myeloid Leukemia: A Systematic Review

2025· review· en· W4414277141 on OpenAlexaboutno aff
Ehab A. M. Elagab, E. Ahmed, Nada Eltigani Hassan Mahgoub, Fatima Suliman Dawod Faky, Nada Abdelrahman Shamina, Nagla Subahi

Bibliographic record

VenueCureus · 2025
Typereview
Languageen
FieldMedicine
TopicAcute Myeloid Leukemia Research
Canadian institutionsnot available
Fundersnot available
KeywordsHematopoietic stem cell transplantationMyeloid leukemiaTransplantationAcute promyelocytic leukemiaSiblingStem cellMeta-analysisClinical trialHematopoietic cell

Abstract

fetched live from OpenAlex

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for adult acute myeloid leukemia (AML), but its outcomes are influenced by donor selection, conditioning regimens, and patient-specific factors. This systematic review synthesizes recent evidence on survival, relapse, non-relapse mortality (NRM), and prognostic factors to guide clinical decision-making. A comprehensive search of PubMed, Scopus, Web of Science, Embase, and ClinicalTrials.gov (January 2020-August 2025) identified 10 studies meeting the inclusion criteria. Studies were evaluated for outcomes (overall survival (OS), disease-free survival (DFS), relapse, and NRM) and risk of bias using the Newcastle-Ottawa Scale (NOS) and Cochrane Risk of Bias (RoB) 2 tool. Haploidentical HSCT improved one-year survival (77.9% vs. 62.0% with chemotherapy) in elderly AML, with lower relapse (16.5% vs. 56.6%). Matched sibling donors (MSD) yielded superior two-year OS (62.4%) compared to unrelated/haploidentical donors, though relapse rates were comparable. Reduced-intensity conditioning (RIC) increased NRM in patients ≥70 years, while nonmyeloablative regimens improved tolerability. Transplantation in complete remission (CR) was critical (five-year OS: 58% vs. 6% for non-CR). Autologous HSCT outperformed allo-HSCT in acute promyelocytic leukemia (APL) complete remission 2 (CR2) (82.4% vs. 64.3% two-year OS). Allo-HSCT benefits intermediate/poor-risk AML, with MSD and CR transplantation offering optimal outcomes. Haploidentical HSCT is viable for older patients lacking matched donors. Future research should prioritize prospective trials to refine donor selection and conditioning strategies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.020
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.007
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.020
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0070.007
Bibliometrics0.0070.008
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0020.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.340
Teacher spread0.313 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCureus→Same topicAcute Myeloid Leukemia Research→French-language works237,207→